The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Characterization of an Adenovirus Gene Transfer Vector Containing an E4 Deletion
Abstract
We describe the construction and characterization of an adenovirus type 2 vector, Ad2E4ORF6, which has been modified in the E4 region to contain only open reading frame 6. When assayed in cultured cells, Ad2E4ORF6 virus replication is slightly delayed but viral DNA synthesis, host-cell protein synthesis shut-off, and virus yield are indistinguishable from wild type. Late protein synthesis is normal with the exception of fiber synthesis, which is reduced approximately 10-fold. Despite the reduced fiber synthesis, Ad2E4ORF6 viral particles appear to contain a full complement of fiber protein. Virus replication in cotton rats indicates that Ad2E4ORF6 is replication defective in vivo. This may have safety implications for the development adenovirus vectors in that virus arising by recombination in the E1 region of an Ad2E4ORF6-based vector would be defective for growth in vivo. The deletion of E4 open reading frames that are not required for virus growth in vitro increases the cloning capacity of adenovirus vectors by 1.9 kb and may be generally useful for the construction of adenovirus vectors containing large cDNA inserts and/or regulatory elements. We describe the inclusion of the A2E4ORF6 modification in a recombinant adenovirus vector, Ad2/CFTR-2, for gene transfer of the human cystic fibrosis transmembrane regulator (CFTR).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thus, second generation vectors have been developed to attenuate chronic immune responses through the deletion of viral gene E2 and E4. The packaging capacities of these vectors are around 8 kb [31,32].”
From Viral Delivery Systems for CRISPR (2019) · cites this paper as [31]
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Characteristics of a human cell line transformed by DNA from human adenovirus type 5
Graham, F. L., Russell, W. C., Smiley, J., & Nairn, R. (1977) · Journal of General Virology · doi:10.1099/0022-1317-36-1-59 · Cited by 4,793 · cited 1×
“…immune re sponses to viral infection Early versions of adenovirus-based gene ttansfer vectors were based on early region 1 (EI) deletion mutants Such vec tors can be grown in the human 293 ceU Une which expresses El proteins from Ad5 sequences integrated into the cell genome (Graham et al, 1977).”
Zabner, J., Couture, L. A., Gregory, R. J., Graham, S. M., Smith, A. E., & Welsh, M. J. (1993) · Cell · doi:10.1016/0092-8674(93)80063-k · Cited by 681
Self-citationPackaging capacity and stability of human adenovirus type 5 vectors
Bett, A. J., Prevec, L., & Graham, F. L. (1993) · Journal of Virology · doi:10.1128/jvi.67.10.5911-5921.1993 · Cited by 472
Halbert, D. N., Cutt, J. R., & Shenk, T. (1985) · Journal of Virology · doi:10.1128/jvi.56.1.250-257.1985 · Cited by 381
Role of early region 3 (E3) in pathogenesis of adenovirus disease.
Ginsberg, H. S., Lundholm-Beauchamp, U., Horswood, R. L., Pernis, B., Wold, W. S., Chanock, R. M., & Prince, G. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.10.3823 · Cited by 290
Self-citationRedundant control of adenovirus late gene expression by early region 4
Bridge, E., & Ketner, G. (1989) · Journal of Virology · doi:10.1128/jvi.63.2.631-638.1989 · Cited by 259
Wold, W. S. M., & Gooding, L. R. (1991) · Virology · doi:10.1016/0042-6822(91)90815-s · Cited by 245
Pathogenesis of adenovirus type 5 pneumonia in cotton rats (Sigmodon hispidus)
Prince, G. A., Porter, D. D., Jenson, A. B., Horswood, R. L., Chanock, R. M., & Ginsberg, H. S. (1993) · Journal of Virology · doi:10.1128/jvi.67.1.101-111.1993 · Cited by 177
Self-citationKleinberger, T., & Shenk, T. (1993) · Journal of Virology · doi:10.1128/jvi.67.12.7556-7560.1993 · Cited by 166
Development and Analysis of Recombinant Adenoviruses for Gene Therapy of Cystic Fibrosis
Rich, D. P., Couture, L. A., Cardoza, L. M., Guiggio, V. M., Armentano, D., Espino, P. C., Hehir, K., Welsh, M. J., Smith, A. E., & Gregory, R. J. (1993) · Human Gene Therapy · doi:10.1089/hum.1993.4.4-461 · Cited by 162
Self-citationWeinberg, D. H., & Ketner, G. W. (1986) · Journal of Virology · doi:10.1128/jvi.57.3.833-838.1986 · Cited by 143
Marton, M. J., Baim, S. B., Ornelles, D. A., & Shenk, T. E. (1990) · Journal of Virology · doi:10.1128/jvi.64.5.2345-2359.1990 · Cited by 143
Obert, S., O'Connor, R. J., Schmid, S. I., & Hearing, P. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.2.1333 · Cited by 139
Weinberg, D. H., & Ketner, G. W. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.17.5383 · Cited by 139
Chen, P. H., Ornelles, D. A., & Shenk, T. E. (1993) · Journal of Virology · doi:10.1128/jvi.67.6.3507-3514.1993 · Cited by 122
Adenovirus Early Region 4 and Viral DNA Synthesis
Bridge, E., Medghalchi, S. M., Ubol, S., Leesong, M., & Ketner, G. W. (1993) · Virology · doi:10.1006/viro.1993.1188 · Cited by 64
Öhman, K., Nordqvist, K., & Akusjärvi, G. (1993) · Virology · doi:10.1006/viro.1993.1234 · Cited by 60
Ranheim, T. S., Shisler, J. L., Horton, T. M., Wold, L. J., Gooding, L. R., & Wold, W. S. M. (1993) · Journal of Virology · doi:10.1128/jvi.67.4.2159-2167.1993 · Cited by 57
Hemström, C., Virtanen, A., Bridge, E., Ketner, G. W., & Pettersson, U. (1991) · Journal of Virology · doi:10.1128/jvi.65.3.1440-1449.1991 · Cited by 48
Eissa, N. T., Chu, C.-S., Danel, C. J., & Crystal, R. G. (1994) · Human Gene Therapy · doi:10.1089/hum.1994.5.9-1105 · Cited by 38
Characterization of adenovirus particles made by deletion mutants lacking the fiber gene
Falgout, B., & Ketner, G. W. (1988) · Journal of Virology · doi:10.1128/jvi.62.2.622-625.1988 · Cited by 37
Complementation of adenovirus E4 mutants by transient expression of E4 cDNA and deletion plasmids
Ketner, G. W., Bridge, E., Virtanen, A., Hemström, C., & Pettersson, U. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.8.3037 · Cited by 34
Brough, D. E., Cleghon, V., & Klessig, D. F. (1992) · Virology · doi:10.1016/0042-6822(92)90900-a · Cited by 31
Research works printed but not linked: 1
- L., 1987, E M B O J., 6, 1733
Cited by
Parks, R. J., Chen, L., Anton, M., Sankar, U., Rudnicki, M. A., & Graham, F. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13565 · Cited by 725
Schiedner, G., Morral, N., Parks, R. J., Wu, Y., Koopmans, S. C., Langston, C., Graham, F. L., Beaudet, A. L., & Kochanek, S. (1998) · Nature Genetics · doi:10.1038/ng0298-180 · Cited by 648
GENE THERAPY: Twenty-First Century Medicine
Verma, I. M., & Weitzman, M. D. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.050304.091637 · Cited by 616
Kochanek, S., Clemens, P. R., Mitani, K., Chen, H. H., Chan, S., & Caskey, C. T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5731 · Cited by 562
Innate Immune Mechanisms Dominate Elimination of Adenoviral Vectors Following In Vivo Administration
Worgall, S., Wolff, G., Falck-Pedersen, E., & Crystal, R. G. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.1-37 · Cited by 491
Metadata
- Authors
- Armentano, D., Sookdeo, C. C., Hehir, K. M., Gregory, R. J., George, J. A. S., Prince, G. A., Wadsworth, S. C., & Smith, A. E.
- Venue
- Human Gene Therapy
- Publisher
- SAGE Publications
- Published
- 1995-10
- Volume
- 6
- Issue
- 10
- Pages
- 1343-1353
- ISSN
- 1043-0342
- 1557-7422
- Cited by
- 111
- References
- 24
- Language
- en
- Licence
- www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.